Skip to content
Screener

Design Therapeutics, Inc. DSGN Q2 2026 earnings

Reported August 3, 2026 · Before market open

EPS-$0.32Beat by $0.02
EPS estimate-$0.34

Next report

Nov 4, 2026 (in 2 months)
EPS estimate-$0.38

FAQ

When did Design Therapeutics, Inc. report Q2 2026 earnings?
Design Therapeutics, Inc. (DSGN) reported Q2 2026 earnings on August 3, 2026 before market open.
What were Design Therapeutics, Inc.'s Q2 2026 revenue and EPS?
Design Therapeutics, Inc. reported eps of $-0.32 for Q2 2026.
Did Design Therapeutics, Inc. beat estimates in Q2 2026?
EPS beat the consensus estimate of $-0.34 by $0.02.
How did Design Therapeutics, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 5.9% from $-0.34.
Where can I find Design Therapeutics, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-329570) and the 10-Q periodic report (0001193125-26-329579) directly on SEC EDGAR. The filing index links above go to sec.gov.